Moreover, Zhuang et al. found that ATP1A1 was increased in hepatocellular carcinoma (HCC) and its downregulation inhibited the tumorigenesis of HCC cells in vivo [45]. Here, ATP1A1 is linked to hepatocellular carcinoma.